Who are Anebulo Pharmaceuticals, Inc.'s main suppliers?

Anebulo Pharmaceuticals, Inc. (ANEB) key suppliers include: VERNALIS, VERNALIS-DEVELOPMENT-LIMITED, Ligand Pharmaceuticals Incorporated, LGNZZ. View the full supplier network at chainsifter.com/chain/ANEB.

Who are Anebulo Pharmaceuticals, Inc.'s major customers?

Anebulo Pharmaceuticals, Inc. (ANEB) key customers include: JPMorgan Chase & Co., JPMorgan Chase & Co., Ligand Pharmaceuticals Incorporated, LGNZZ, JFL-CAPITAL-MANAGEMENT-LLC. View the full customer network at chainsifter.com/chain/ANEB.

What sector is Anebulo Pharmaceuticals, Inc. in?

Anebulo Pharmaceuticals, Inc. (ANEB) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Anebulo Pharmaceuticals, Inc. Suppliers, Customers & Supply Chain (ANEB)

4Suppliers

5Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Anebulo Pharmaceuticals, Inc. (ANEB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships

4Distinct source URLs

4High confidence

0.776Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Anebulo Pharmaceuticals, Inc. Suppliers

Ticker	Name	Confidence	Evidence
VERNALIS	VERNALIS	90%	We have access to certain regulatory materials, including study reports from clinical and non-clinical trials, under Vernalis' control.
VERNALIS-DEVELOPMENT-LIMITED	VERNALIS-DEVELOPMENT-LIMITED	90%	The Company licensed certain intellectual property, know-how and clinical trial data from Vernalis Development Limited
LGND	Ligand Pharmaceuticals Incorporated	72%	Reciprocal relationship from LGND graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from LGND graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from LGND g…
LGNZZ	LGNZZ	72%	Reciprocal relationship from LGNZZ graph: expected to expire until 2033. As described herein, we have entered into a settlement agreement with Teva and Acrotech Biopharma (the holder of the NDA for E…

Anebulo Pharmaceuticals, Inc. Customers

Ticker	Name	Confidence	Evidence
JPM-PD	JPMorgan Chase & Co.	72%	ffect our current and projected business operations and our financial condition and results of operations. Adverse developments that affect financial institutions, such as events involving liquidity …
JPM-PD	JPMorgan Chase & Co.	72%	Reciprocal relationship from JPM-PD graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from JPM-PD graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from JP…
LGND	Ligand Pharmaceuticals Incorporated	72%	Reciprocal relationship from LGND graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from LGND graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from LGND g…
LGNZZ	LGNZZ	72%	Reciprocal relationship from LGNZZ graph: Reciprocal relationship from ANEB graph: Reciprocal relationship from LGNZZ graph: expected to expire until 2033. As described herein, we have entered into a…
JFL-CAPITAL-MANAGEMENT-LLC	JFL-CAPITAL-MANAGEMENT-LLC	62%	Product candidates currently under development will require significant additional research and development efforts, including extensive nonclinical and clinical testing and regulatory approval prior…

Anebulo Pharmaceuticals, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ANEB-DEBT-7757	Warrants outstanding: 26626710	90%	xbrl warrant detail from xbrl 2021-06-30.

Anebulo Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Anebulo Pharmaceuticals, Inc..

Anebulo Pharmaceuticals, Inc. Ownership

Holder	Name	Confidence	Evidence
ANEB-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 2 tracked holders.

Anebulo Pharmaceuticals, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
LGNZZ	LIGAND PHARMACEUTICALS INC	100.00	1	['customer', 'supplier']
JPM-PD	JPMorgan Chase & Co.	100.00	1	['customer']
LGND	Ligand Pharmaceuticals Incorporated	100.00	1	['customer', 'supplier']
DLR-PJ	DIGITAL REALTY TRUST, INC.	50.00	2
AGEN	Agenus Inc.	50.00	2
ALLO	Allogene Therapeutics, Inc.	50.00	2
CNTA	Centessa Pharmaceuticals plc	50.00	2
CURX	Curanex Pharmaceuticals Inc	50.00	2
LONA	LeonaBio, Inc.	50.00	2
CRMD	CorMedix Inc.	50.00	2
JPM-PM	JPMORGAN CHASE & CO	50.00	2
ACGL	Arch Capital Group Ltd.	50.00	2
CB	Chubb Limited	50.00	2
ELUT	Elutia Inc.	50.00	2
JJETF	BARCLAYS BANK PLC	50.00	2
CINF	Cincinnati Financial Corporation	50.00	2
IDAI	T Stamp Inc.	50.00	2
HOLX	Hologic, Inc.	50.00	2
DNTH	Dianthus Therapeutics, Inc.	50.00	2
BSX	Boston Scientific Corporation	50.00	2

Anebulo Pharmaceuticals, Inc. Supply Chain